Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cocaine | 10 | 2023 | 555 | 1.480 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2023 | 58 | 1.440 |
Why?
|
| Histone Deacetylases | 3 | 2017 | 99 | 1.070 |
Why?
|
| Anhedonia | 1 | 2023 | 15 | 0.880 |
Why?
|
| Nucleus Accumbens | 6 | 2023 | 417 | 0.750 |
Why?
|
| Dopamine Uptake Inhibitors | 4 | 2019 | 152 | 0.720 |
Why?
|
| Conditioning, Operant | 3 | 2019 | 241 | 0.650 |
Why?
|
| Cyclic AMP | 4 | 2017 | 223 | 0.460 |
Why?
|
| Synapses | 5 | 2023 | 222 | 0.430 |
Why?
|
| Cytoskeletal Proteins | 3 | 2019 | 108 | 0.410 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2012 | 55 | 0.410 |
Why?
|
| Reward | 3 | 2016 | 201 | 0.400 |
Why?
|
| Cyclin-Dependent Kinase 5 | 2 | 2012 | 9 | 0.390 |
Why?
|
| Mice, Inbred C57BL | 10 | 2023 | 2791 | 0.390 |
Why?
|
| Mice | 14 | 2023 | 8474 | 0.380 |
Why?
|
| Neurons | 6 | 2017 | 881 | 0.300 |
Why?
|
| Animals | 18 | 2023 | 20880 | 0.300 |
Why?
|
| Nerve Tissue Proteins | 2 | 2019 | 290 | 0.300 |
Why?
|
| Syntaxin 1 | 1 | 2007 | 6 | 0.290 |
Why?
|
| Self Administration | 5 | 2023 | 419 | 0.280 |
Why?
|
| Drug-Seeking Behavior | 3 | 2023 | 213 | 0.280 |
Why?
|
| Extinction, Psychological | 2 | 2018 | 240 | 0.270 |
Why?
|
| Anxiety | 2 | 2019 | 422 | 0.260 |
Why?
|
| Neuronal Plasticity | 6 | 2016 | 274 | 0.250 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 230 | 0.250 |
Why?
|
| Dendritic Spines | 3 | 2010 | 76 | 0.240 |
Why?
|
| Social Behavior | 2 | 2023 | 164 | 0.240 |
Why?
|
| Corpus Striatum | 3 | 2017 | 278 | 0.230 |
Why?
|
| Epigenesis, Genetic | 3 | 2023 | 163 | 0.230 |
Why?
|
| Depression | 2 | 2023 | 942 | 0.220 |
Why?
|
| Heroin | 1 | 2023 | 49 | 0.210 |
Why?
|
| Fragile X Mental Retardation Protein | 2 | 2014 | 20 | 0.210 |
Why?
|
| Mice, Knockout | 5 | 2019 | 1692 | 0.210 |
Why?
|
| Rats | 6 | 2018 | 5300 | 0.210 |
Why?
|
| Exploratory Behavior | 2 | 2019 | 79 | 0.190 |
Why?
|
| Myogenic Regulatory Factors | 3 | 2010 | 15 | 0.190 |
Why?
|
| Brain | 4 | 2018 | 2176 | 0.190 |
Why?
|
| Behavior, Animal | 4 | 2018 | 470 | 0.190 |
Why?
|
| Mice, Transgenic | 2 | 2023 | 1033 | 0.170 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2018 | 33 | 0.160 |
Why?
|
| Mass Spectrometry | 2 | 2012 | 284 | 0.160 |
Why?
|
| Substance-Related Disorders | 2 | 2018 | 1242 | 0.150 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 56 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2019 | 1745 | 0.150 |
Why?
|
| Prefrontal Cortex | 1 | 2023 | 639 | 0.150 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2016 | 15 | 0.140 |
Why?
|
| Analysis of Variance | 3 | 2016 | 1040 | 0.140 |
Why?
|
| Stress, Psychological | 1 | 2023 | 824 | 0.140 |
Why?
|
| Central Nervous System Sensitization | 1 | 2016 | 8 | 0.140 |
Why?
|
| Fear | 1 | 2017 | 239 | 0.140 |
Why?
|
| Behavior, Addictive | 1 | 2018 | 317 | 0.130 |
Why?
|
| Cells, Cultured | 4 | 2017 | 2673 | 0.120 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2012 | 93 | 0.120 |
Why?
|
| Transfection | 2 | 2012 | 782 | 0.110 |
Why?
|
| Cognition | 1 | 2016 | 512 | 0.110 |
Why?
|
| Phosphorylation | 3 | 2017 | 1200 | 0.110 |
Why?
|
| Sweetening Agents | 1 | 2012 | 23 | 0.100 |
Why?
|
| Food Preferences | 1 | 2012 | 46 | 0.100 |
Why?
|
| Sucrose | 1 | 2012 | 58 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 1293 | 0.100 |
Why?
|
| Protein Phosphatase 2 | 1 | 2012 | 67 | 0.100 |
Why?
|
| Hippocampus | 2 | 2016 | 471 | 0.100 |
Why?
|
| Embryo, Mammalian | 1 | 2012 | 176 | 0.100 |
Why?
|
| Male | 8 | 2019 | 37283 | 0.100 |
Why?
|
| Septins | 2 | 2010 | 3 | 0.100 |
Why?
|
| Mutation | 2 | 2017 | 1213 | 0.090 |
Why?
|
| COS Cells | 2 | 2010 | 155 | 0.090 |
Why?
|
| GTP-Binding Proteins | 1 | 2010 | 231 | 0.080 |
Why?
|
| Transcription Factor AP-1 | 1 | 2008 | 61 | 0.080 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2008 | 80 | 0.080 |
Why?
|
| Maze Learning | 2 | 2019 | 138 | 0.080 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2008 | 95 | 0.080 |
Why?
|
| Models, Biological | 1 | 2012 | 981 | 0.070 |
Why?
|
| Electric Stimulation | 2 | 2018 | 218 | 0.070 |
Why?
|
| Synaptic Transmission | 1 | 2008 | 236 | 0.070 |
Why?
|
| Subcellular Fractions | 1 | 2007 | 92 | 0.070 |
Why?
|
| Synaptosomes | 1 | 2007 | 57 | 0.070 |
Why?
|
| Microglia | 1 | 2008 | 143 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2008 | 432 | 0.070 |
Why?
|
| Lipopolysaccharides | 1 | 2008 | 455 | 0.070 |
Why?
|
| MEF2 Transcription Factors | 3 | 2010 | 36 | 0.060 |
Why?
|
| Humans | 5 | 2023 | 68549 | 0.060 |
Why?
|
| Protein Binding | 1 | 2007 | 1027 | 0.060 |
Why?
|
| Cocaine-Related Disorders | 1 | 2008 | 504 | 0.060 |
Why?
|
| Time Factors | 1 | 2012 | 4655 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2016 | 2550 | 0.050 |
Why?
|
| Reinforcement Schedule | 1 | 2018 | 59 | 0.040 |
Why?
|
| Receptors, AMPA | 1 | 2019 | 99 | 0.040 |
Why?
|
| Histone Demethylases | 1 | 2018 | 22 | 0.040 |
Why?
|
| Chromatin | 1 | 2018 | 76 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 196 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2018 | 193 | 0.040 |
Why?
|
| Biophysical Phenomena | 1 | 2016 | 25 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2017 | 155 | 0.040 |
Why?
|
| Swimming | 1 | 2016 | 38 | 0.040 |
Why?
|
| Protein Transport | 1 | 2017 | 280 | 0.030 |
Why?
|
| Long-Term Potentiation | 1 | 2016 | 53 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2017 | 305 | 0.030 |
Why?
|
| Recurrence | 1 | 2018 | 948 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2016 | 765 | 0.030 |
Why?
|
| Ceramides | 1 | 2016 | 578 | 0.030 |
Why?
|
| Motor Activity | 1 | 2014 | 621 | 0.020 |
Why?
|
| Miniature Postsynaptic Potentials | 1 | 2010 | 3 | 0.020 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2010 | 27 | 0.020 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2010 | 87 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2010 | 122 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2010 | 251 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2010 | 204 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2010 | 246 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2010 | 396 | 0.020 |
Why?
|
| Receptors, Dopamine D5 | 1 | 2008 | 5 | 0.020 |
Why?
|
| Neostriatum | 1 | 2008 | 60 | 0.020 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2008 | 87 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2010 | 215 | 0.020 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2008 | 60 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 562 | 0.020 |
Why?
|
| Nerve Net | 1 | 2010 | 180 | 0.020 |
Why?
|
| Losartan | 1 | 2008 | 45 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2008 | 203 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2008 | 189 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 567 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2008 | 371 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2008 | 447 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 498 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 1752 | 0.020 |
Why?
|
| Gene Expression | 1 | 2008 | 770 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2010 | 1663 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2008 | 2083 | 0.010 |
Why?
|
| Pregnancy | 1 | 2008 | 2334 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2008 | 2689 | 0.010 |
Why?
|
| Female | 2 | 2014 | 38021 | 0.010 |
Why?
|